Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. - Wikidata - wikimedia - TriplyDB

Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

http://www.wikidata.org/entity/Q36088594

about

The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.Prevalence of intracardiac shunting in children with sickle cell disease and stroke Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions The PhysioFlow thoracic impedancemeter is not valid for the measurements of cardiac hemodynamic parameters in chronic anemic patients The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditions Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders Updated Mechanisms of Sickle Cell Disease-Associated Chronic pain Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.Pulmonary hypertension in sickle cell disease: relevance to children.Pathophysiology and treatment of pulmonary hypertension in sickle cell disease Hemodynamic predictors of mortality in adults with sickle cell disease Sickle cell anemia-associated pulmonary arterial hypertension.Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.Stroke in sickle cell anemia: alternative etiologies.Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension.Cardiovascular abnormalities in sickle cell disease.Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.Pulmonary hypertension in children with sickle cell disease.Chronic Pulmonary Complications of Sickle Cell Disease.Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia.Exercise-Induced Abnormal Increase of Systolic Pulmonary Artery Pressure in Adult Patients With Sickle Cell Anemia: An Exercise Stress Echocardiography Study.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension associated with hemolytic anemia.Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension.Sickle cell disease related mortality in the United States (1999-2009).The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.Pulmonary hypertension in hemolytic anemias The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.Is resistance futile?: Hemodynamics in sickle cell disease.Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease.

P2860

Q28512770-21BC1E4E-D753-4821-BB90-15C942F03DE7 Q30481575-FC482D48-365E-4BDB-AA77-749A79D4833F Q33551127-1545BBF8-7B84-45BE-B0B3-EE3956CB9FB6 Q33803027-0B62F3DE-05B5-4261-BB73-19B9747A34FB Q33899415-79C0295A-A2A1-446E-8033-3847DE101519 Q34038886-F0D30B6A-E7BD-45FB-9022-064AB2F27708 Q34470834-90716554-F561-4A58-929A-0985F3A32E48 Q34606420-D83FDEAF-E007-4852-BDA1-B1021C53C315 Q34733041-9F697035-9073-46EC-AC0D-B14B3682A8F3 Q34898802-3F3B223F-54C1-4052-9645-CEF8A99DEA65 Q34992760-B73DAE88-60B0-4886-96F3-D88331EA6455 Q35027985-94522FB9-EE4B-47C9-B2C4-21577FC090D1 Q35203857-0B8E8C90-67B7-4F3B-8560-49590C843B24 Q35590733-1FCDE347-DED8-418B-B258-FCA6243CA2A1 Q35972703-89968853-C161-4D71-A70F-6A6245926610 Q36119758-E18E593C-AE26-4C63-90FE-EEF2B164A819 Q36120873-FAE44DD1-0DC0-47A0-8552-81996693CFFD Q36596861-7EB07173-EEC5-4D6F-8EFB-2EF2B873AA54 Q36999803-B587B309-94C2-4445-B7DE-D7644BC926EA Q37008399-B2EC9A8D-E5D4-453A-B0E7-A97CF6423BAF Q37112890-58E65391-CEAA-4025-8F8C-592588AD0A17 Q37255704-A42A9180-7F51-4D1F-A9BE-FB5631B72F77 Q37258558-AACABD8A-1C8B-4550-BCAE-905B664B919F Q37340140-B093AC9A-2FEE-4D1C-B73E-26B2CBA4D54B Q37354098-3253F7E4-FB65-4340-A296-2E7CEEC47880 Q37435068-B20509FC-3C48-4294-A130-94415BFC6599 Q37565002-E636959F-CDC0-4995-8EAC-BA2F20F32801 Q37698249-491B9D13-3422-4B74-8361-4BAB1BDB18AC Q37867674-48E17900-F532-48E8-B3B0-361F3CFDE458 Q38719970-40273257-AEE7-462D-9CB1-8AE65C61B9B5 Q38957756-D70E2BBA-F24A-480E-AEE7-9B7F5B20F0EE Q41674212-48C6D9D4-6D5B-4CB4-9F57-E23BDB6F8915 Q41975944-DEBA6417-853E-4AC6-883C-B5CB26DF3D2B Q42125644-ABA53F8C-13DA-4402-B7D6-11E647B526DB Q42264563-FE2B3E3F-81E8-4B10-8216-C9898C6BF3D8 Q42349186-F8AC594F-212D-4039-A345-1FE2C840DF1F Q42415504-EB4F4E54-A8CF-477F-BCDD-56B5CD313679 Q42454675-0A772341-D2D3-4448-8A6F-5E3D74C47D72 Q43098409-8B003F06-3FFB-428D-87AA-E88835E9C0E9 Q46724819-1257C6B0-DDD8-4BD4-A1B0-28BA8F94EEFE

P2860

Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

http://www.wikidata.org/entity/Q36088594

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@ast

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@en

type

label

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@ast

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@en

prefLabel

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@ast

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@en

P1433

Q36088594-10CAF17E-8E5E-4E2E-8116-B2CF0AA667C4

P1476

Q36088594-C730C77B-4A31-4370-8F7E-07B72888374F

P2093

Q36088594-17282B3C-F652-4729-9DDA-ED5AA970E954

Q36088594-2438AEAF-4745-49C3-AE1E-9F37E2446B88

Q36088594-30C5D8E8-29E9-4804-B039-DB3F9FB2A794

Q36088594-6FCDD8A5-C5D3-420B-8D08-9029C88A6758

Q36088594-7226F7F1-3387-469C-B23A-35DD2C92FB38

Q36088594-78A4ADE7-5EB5-4D3B-AF26-A44C6697DB39

Q36088594-AD671399-D622-4493-ABD4-374F0B554AB7

Q36088594-B7024E45-0311-403F-B556-0479725B2E68

Q36088594-CF02FDAC-CCCC-44E2-80C4-FD97BE441434

Q36088594-DE810E96-DA71-4BD7-9187-B528CF2576E0

P2860

Q36088594-0FAB3EFF-7046-4C52-A589-DA9EEA6E7D78

Q36088594-1EAE2BED-8023-4EAC-A689-9659748455E0

Q36088594-22086ADD-2C12-46D5-96F3-E3C7E5A1700B

Q36088594-4490619C-3066-4920-93AB-C581A874C5EC

Q36088594-471E11BA-233E-44EE-9A26-B39CF0FF98F2

Q36088594-5F83EB6D-1BE3-4A35-A741-848F834CA0A6

Q36088594-68E982A0-65EB-45A1-A742-D22707F6C545

Q36088594-719F3EEE-5BBE-4CAE-BB48-8ACE40FDD969

Q36088594-7203A2D5-AA11-4C22-90F0-CEC353CA191A

Q36088594-73C65887-3B7B-4E54-A679-6B1D2AE098D6

P304

Q36088594-A6E24E9D-B7A4-496B-B9E4-714E6FCB7B3C

P31

Q36088594-81E59E7F-2345-46AA-8E9A-53F9375F7644

P356

Q36088594-90DEED89-F5B9-4C06-9208-4AA756B7EF1E

P407

Q36088594-272CD97F-7ED1-4F67-93EA-F1DE8EEC3CE6

P433

Q36088594-2B76E7F9-A03D-4C5D-8E35-16E38CCC65B9

P478

Q36088594-A9940167-0458-43E0-B336-EFC5470AB22A

P50

Q36088594-AF8FA71D-B423-4746-910F-5A0F16B766AC

Q36088594-FD39E5CD-F5E5-4483-B7AF-35B5EE3C1BA5

P577

Q36088594-1FA44658-1618-48FA-B23E-C593E3284229

P5875

Q36088594-7D404989-2B42-4FB6-94F9-72A5ABC69553

P698

Q36088594-B319DE53-E96E-4CA2-BF05-A798C8FBD1A2

P921

Q36088594-B06E948F-74C0-436A-BACA-F06C02DA8F23

P932

Q36088594-DBB3598B-579F-4BDE-A3A3-C9383BB1B3CA

P356

J.1365-2141.2006.06417.X

P1433

British Journal of Haematology

P1476

Severity of pulmonary hyperten ...... ents with sickle cell disease.

@en

P2093

A Kyle Mack

http://www.w3.org/2001/XMLSchema#string

Christopher Barnett

http://www.w3.org/2001/XMLSchema#string

Inez Ernst

http://www.w3.org/2001/XMLSchema#string

James P Nichols

http://www.w3.org/2001/XMLSchema#string

Lori A Hunter

http://www.w3.org/2001/XMLSchema#string

Peter Macarthur

http://www.w3.org/2001/XMLSchema#string

Roberto F Machado

http://www.w3.org/2001/XMLSchema#string

Sabrina Martyr

http://www.w3.org/2001/XMLSchema#string

Vandana Sachdev

http://www.w3.org/2001/XMLSchema#string

Wynona A Coles

http://www.w3.org/2001/XMLSchema#string

P2860

Hemoglobin and the paracrine and endocrine functions of nitric oxide

Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels.

Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency.

Primary pulmonary hypertension. Its association with microangiopathic hemolytic anemia and thrombocytopenia.

Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives.

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease.

Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin.

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

P304

319-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2006.06417.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Gregory J. Kato

P577

2006-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6643917

http://www.w3.org/2001/XMLSchema#string

P698

17156401

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

2040190

http://www.w3.org/2001/XMLSchema#string